NCT02761161View on ClinicalTrials.gov

Treatment of Sleep Disturbances in Trauma-affected Refugees

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions
Post Traumatic Stress DisorderDepression
Interventions
DRUG

Mianserin

mianserin is add-on treatment to treatment as usual. Max dose 30 mg day.

BEHAVIORAL

Imagery Rehearsal Therapy

IRT is add-on treatment to treatment as usual.

Trial Locations (1)

2750

Competence Centre for Transcultural Psychiatry, Copenhagen

All Listed Sponsors
collaborator

Danish Center for Sleep Medicine

OTHER

lead

Mental Health Services in the Capital Region, Denmark

OTHER

NCT02761161 - Treatment of Sleep Disturbances in Trauma-affected Refugees | Biotech Hunter | Biotech Hunter